Article Details
Retrieved on: 2024-09-13 18:57:24
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights Japan's approval of CSL and Arcturus Therapeutics' self-amplifying mRNA COVID-19 vaccine, KOSTAIVE®, underscoring its innovative approach to enhancing public health. It also mentions vaccine distribution and CSL's broader public health commitment.
Article found on: www.precisionvaccinations.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here